About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
2020 ACR Update on Giant Cell Arteritis: Is Mavrilimumab Effective for Reducing the Risk for Flare and Maintaining Sustained Remission?
By
RheumNow
FEATURING
Sarah Mackie
,
David Liew
,
Richard Conway
,
Leonard Calabrese
By
RheumNow
FEATURING
Sarah Mackie
,
David Liew
,
Richard Conway
,
Leonard Calabrese
109 views
November 19, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
09:07
GSK
Identifying Eosinophilic Granulomatosis With Polyangiitis and Hypere…
Feat.
M. O'Connor
Featured Video
15:59
GSK
An Efficacy and Safety Review for Patients With Severe Eosinophilic …
Feat.
Y. Goldman
Related Content
AUTOPLAY
ON
41:57
University of Washington School of Medicine
Introduction to Ultrasound in Large Vessel Vasculitis - How to Corre…
Feat.
W. Schmidt
16:02
Vanderbilt University Medical Center (VUMC)
72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…
Feat.
K. Byram
20:52
Cleveland Clinic Rheumatology
Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…
Feat.
L. Calabrese
25:36
Cleveland Clinic Rheumatology
When Should Biologic Agents be Introduced in Giant Cell Arteritis an…
Feat.
K. Warrington
09:13
Highlights from ACR Convergence 2023
ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Gian…
Feat.
E. Treppo
07:43
Cleveland Clinic Rheumatology and Immunology Series
Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Shor…
Feat.
A. Brown
04:27
Cleveland Clinic Rheumatology
The Cat in Wolves Clothing – Is It ANCA Vasculitis or Bartonella &am…
Feat.
A. Brown
29:50
Cleveland Clinic Rheumatology
Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?
Feat.
L. Calabrese,
G. Hoffman
17:08
Keck School of Medicine of USC
Historical Considerations of Vasculitis, Lupus and Autoimmune Diseas…
Feat.
R. Panush
05:55
Cleveland Clinic Rheumatology
A Case of GPA With Persistent Shortness of Breath, Monitoring Patien…
Feat.
A. Villa-Forte
16:51
RheumNow
PMR/GCA Panel EULAR 2022
Feat.
R. Conway,
S. Mackie,
M. Putman
07:40
Cleveland Clinic Rheumatology
Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…
Feat.
C. Calabrese
14:17
Highlights from ACR Convergence 2023
ACR Convergence 2023 Highlights: The Clinical Characteristics and …
Feat.
V. Tiwari
33:55
Cleveland Clinic Rheumatology
The Three Musketeers: GCA, PMR, and RA
Feat.
W. Rigby
05:35
Highlights from ACR Convergence 2023
ACR Convergence 2023 Highlights: Magnetic Resonance Imaging Reflects…
Feat.
L. Christ
48:25
Cleveland Clinic Rheumatology
CNS Vasculitis: Diagnostic Update
Feat.
L. Calabrese
19:49
RheumNow
EULAR 2020 Vasculitis Abstracts Discussion: Highlights in Polymyalgi…
Feat.
J. Cush,
D. Liew,
L. Calabrese,
S. Mackie
13:37
Highlights from ACR Convergence 2023
ACR Convergence 2023 Highlights: Update of EULAR Recommendations for…
Feat.
W. Schmidt
20:01
RheumNow
ACR 2021 Updates on Giant Cell Arteritis & Polymyalgia Rheumatic…
Feat.
L. Calabrese,
D. Liew,
R. Conway,
S. Mackie
04:49
Lisa Christ
Long-term Efficacy of Tocilizumab Monotherapy After Ultra-short Gluc…
